Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

NCT01160354 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Plerixafor
DRUG: Clofarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]